Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Mallon

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasisSuzanne Hagan, Fahd Al-Mulla, Elizabeth Mallon, et al.
Human Pathology|April 12, 2013
Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancerZahra M A Mohammed, Clare Orange, Donald C McMillan, et al.
Histopathology|July 4, 2012
Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancerZahra M A Mohammed, James J Going, Donald C McMillan, et al.
Cancer Medicine|May 18, 2023
High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patientsElizabeth Morrow, Kathryn Pennel, Phimmada Hatthakarnkul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast CancerMitch Dowsett, Ivana Sestak, Richard Buus, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
JAMA Oncology|February 17, 2018
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialIvana Sestak, Richard Buus, Jack Cuzick, et al.
Plos One|June 27, 2014
Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancerNicola Ferrari, Zahra M A Mohammed, Colin Nixon, et al.
Cancer Medicine|April 13, 2026
High Expression of PAPP-A Predicts Poor Outcomes in Oestrogen Receptor-Positive Breast Cancer PatientsZeanap Mabruk, Esme Bullock, Xue Xiao, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
SIRT2: tumour suppressor or tumour promoter in operable breast cancer?Liane M McGlynn, Samer Zino, Alasdair I MacDonald, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasisSuzanne Hagan, Fahd Al-Mulla, Elizabeth Mallon, et al.
Human Pathology|April 12, 2013
Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancerZahra M A Mohammed, Clare Orange, Donald C McMillan, et al.
Histopathology|July 4, 2012
Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancerZahra M A Mohammed, James J Going, Donald C McMillan, et al.
Cancer Medicine|May 18, 2023
High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patientsElizabeth Morrow, Kathryn Pennel, Phimmada Hatthakarnkul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast CancerMitch Dowsett, Ivana Sestak, Richard Buus, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
JAMA Oncology|February 17, 2018
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialIvana Sestak, Richard Buus, Jack Cuzick, et al.
Plos One|June 27, 2014
Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancerNicola Ferrari, Zahra M A Mohammed, Colin Nixon, et al.
Cancer Medicine|April 13, 2026
High Expression of PAPP-A Predicts Poor Outcomes in Oestrogen Receptor-Positive Breast Cancer PatientsZeanap Mabruk, Esme Bullock, Xue Xiao, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
SIRT2: tumour suppressor or tumour promoter in operable breast cancer?Liane M McGlynn, Samer Zino, Alasdair I MacDonald, et al.
Pageof 4